Filtered By:
Vaccination: Cancer Vaccines
This page shows you your search results in order of relevance. This is page number 4.
Order by Relevance | Date
Total 243 results found since Jan 2013.
Designing of DNA Vaccine Based on a Secretory Form of Major Capsid Protein of Human Papillomavirus Type 18
In conclusion, pVAX1-tPA-PADRE-L1 recombinant plasmid is a highly immunogenic construct and suggests as a promising candidate for vaccine development against HPV type 18 in low-middle-income countries.PMID:34664812 | DOI:10.18502/ijaai.v20i5.7403
Source: Iranian Journal of Allergy, Asthma and Immunology - October 19, 2021 Category: Allergy & Immunology Authors: Somayeh Shokri Shahab Mahmoudvand Manoochehr Makvandi Reza Taherkhani Mohammad Rashno Farid Azizi Jalilian Kambiz Ahmadi Angali Mohammad Ali Foroughi Source Type: research
Predictors of seroconversion following COVID-19 vaccination
CONCLUSION: Vaccine responses vary by age and sex, with males showing lower rates of seroconversion as compared to females. Primary immunodeficiency along with active malignancy and ongoing immunosuppression with steroids and/or B-cell depletion therapy appeared to be the most common characteristics for those with lack of vaccine seroconversion following COVID-19 vaccination.PMID:35640775 | PMC:PMC9144839 | DOI:10.1016/j.anai.2022.05.026
Source: Annals of Allergy, Asthma and Immunology - May 31, 2022 Category: Allergy & Immunology Authors: Sergio E Chiarella Sarah M Jenkins Carin Y Smith Vikas Prasad Fnu Shakuntulla Vaibhav Ahluwalia Vivek N Iyer Elitza S Theel Avni Y Joshi Source Type: research
In vitro and in vivo Evidence on Intra-tumor Injection of Allogeneic Serum for Immunotherapy in a Mouse Model of Colon Cancer
Iran J Allergy Asthma Immunol. 2022 Oct 26;21(5):549-560. doi: 10.18502/ijaai.v21i5.11042.ABSTRACTIt is believed that preformed antibodies are responsible for blood transfusion reactions and transplant rejections. In order to remove a tumor, the tissue must be rejected. On the basis of transfusion reaction and transplantation immunology, we hypothesized that allogeneic serum can inhibit tumor growth when injected intra-tumor. Initially, an in vitro cytotoxicity test was conducted using the C57BL/6 serum (intact or decomplemented) in combination with the BALB/c-originating CT26 cell line. The CT26 cell line was used to esta...
Source: Iranian Journal of Allergy, Asthma and Immunology - November 7, 2022 Category: Allergy & Immunology Authors: Erfan Basirat Danial Dehghan Ardeshir Abbasi Nafiseh Pakravan Source Type: research
